KELECHI NWAORGU: Open Payments
NPI 1598273237 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 70 payments from 10 companies in 2025. Trend: 2023 $87 · 2024 $1,607 · 2025 $1,748
Food & beverage: $1,566Education: $183
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $435 |
| Axsome Therapeutics, Inc. | 12 | $286 |
| Otsuka America Pharmaceutical, Inc. | 10 | $236 |
| Alkermes, Inc. | 9 | $182 |
| Neurocrine BioSciences, Inc. | 5 | $163 |
| Bausch Health US, LLC | 6 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| ABBVIE INC. | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
Products named: Auvelity, ARISTADA, INGREZZA, REXULTI, APLENZIN, AUSTEDO XR, FANAPT, VRAYLAR.
Industry payments across WA — which companies pay providers there.
